Changes in antibiotic resistance rates of invasive Haemophilus influenzae isolates in England and Wales over the last 20 years

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 4, 2008, Pages 776-779

  Ladhani, Shamez ^a   Heath, Paul T ^b   Ramsay, Mary E ^a   Slack, Mary P E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antimicrobial resistance surveillance; Haemophilus influenzae serotype b; Trimethoprim

Indexed keywords

AMPICILLIN; CEFOTAXIME; CHLORAMPHENICOL; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; RIFAMPICIN; TETRACYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONHUMAN; STATISTICAL SIGNIFICANCE; TREND STUDY; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BLOOD; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ENGLAND; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; SEROTYPING; WALES;

EID: 52949123691     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn274     Document Type: Article

References (10)

1. Turk DC. The pathogenicity of Haemophilus influenzae. J Med Microbiol 1984; 18: 1-16.
2. Jansen WT, Verel A, Beitsma M et al. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J Antimicrob Chemother 2006; 58: 873-7.
3. Turnak MR, Bandak SI, Bouchillon SK et al. Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countries. Clin Microbiol Infect 2001; 7: 671-7.
4. Jacobs MR, Felmingham D, Appelbaum PC et al. The Alexander Project 1998-2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52: 229-46.
5. Ladhani S, Slack MP, Heath PT et al. Changes in ascertainment of Hib and its influence on the estimation of disease incidence in the United Kingdom. Epidemiol Infect 2007; 135: 861-7.
6. Falla TJ, Crook DW, Brophy LN et al. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 1994; 32: 2382-6.
7. Report of the Working Party on Antibiotic Sensitivity Testing of the British. Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27 Suppl D: 1-50.
8. Anon. Haemophilus influenzae type b (Hib). In: Salisbury DM, Ramsay ME, Noakes K, eds. Immunisation Against Infectious Disease. London: The Stationary Office, 2006; 127-42.
9. Sharland M, Kendall H, Yeates D et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: Time trend analysis. BMJ 2005; 331: 328-9.
10. Anonymous. Guidelines for the management of acute urinary tract infection in childhood. Report of a Working Group of the Research Unit, Royal College of Physicians. J R Coll Physicians Lond 1991; 25 36-42.